Adjunctive use of abciximab during cerebrovascular angioplasty and stenting

Seminars in Neurosurgery

Volumn 13, Issue 3, 2002, Pages 245-255

  Armonda, Rocco A ^a,b,c   Benitz, Ronald ^c   Rossenwasser, Robert H ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b National Capital Consortium   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Abciximab; Carotid stenting; Neurological risks

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN DERIVATIVE; TICLOPIDINE; TIROFIBAN; UROKINASE; XEMILOFIBAN;

ADULT; AGED; ANGIOPLASTY; BRAIN HEMORRHAGE; CAROTID ANGIOPLASTY; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID STENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INFUSION; DRUG MECHANISM; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; REVIEW; RISK FACTOR; STENT; STROKE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VERTEBRAL ARTERY;

EID: 0038410159     PISSN: 15268012     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-39818     Document Type: Review

References (33)

1. Connors JJ, Seidenwurm D, Wojak JC, et al. Treatment of atherosclerotic disease at the cervical carotid bifurcation: current status and review of the literature. Am J Neuroradiol 2000;21:444-450
2. Mericle RA, Kim SH, Lanzino G, et al. Carotid artery angioplasty and use of stents in high-risk patients with contralateral occlusions. J Neurosurg 1999;90:1031-1036
3. Yadav JS, Roubin GS, Iyer S. Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376-381
4. Teitelbaum GP, Lefkowitz MA, Giannotta SL. Carotid angioplasty and stenting in high-risk patients. Surg Neurol 1998;56:300-312
5. Wholey MH, Wholey M, Bergeron P, et al. Current global status of carotid stent placement. Catheterization and Cardiovascular Diagnosis 1998;44:1-6
6. Mathur A, Roubin G, Gomez CR, et al. Elective carotid artery stenting in the presence of contralateral occlusion. Am J Cardiol 1998;81:1315-1317
7. Al-Mubarak N, Roubin GS, Gomez CR, et al. Carotid artery stenting in patients with high neurologic risks. Am J Cardiol 1999;83:1411-1413
8. Al-Mubarak N, Roubuin GS, Liu MW, et al. Early results of percutaneous intervention for severe coexisting carotid and coronary artery disease. Am J Cardiol 1999;84:600-602
9. New G, Roubin GS, Iyer SS, Vitek JJ. Carotid artery stenting: rationale, indications, and results. Comp Ther 1999;25:438-445
10. Morris P, Martin EM, Braden G. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. Am J Neuroradiol 1999;20:1688-1694
11. Quereshi AI, Luft AR,Janardhan V, et al. Idendfication of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke 2000;31:376-382
12. Jeong MH, Owen WG, Staab ME, et al. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. Cathet Cardiovascular Diagn 1996;38:38-43
13. Kapadia SR, Bajzer CI, Ziada KM, et al. Initial experience of glycoprotien IIb/lIIa inhibition with abciximab during carotid stenting: a safe adjunctive therapy. Abstracts Angiography and Interventional Cardiology, ACCIS 2000, JAAC 86A Feb 2000
14. Horwitz A. Integrins and health. Scientific American 1997;68-75
15. The Abciximab in Ischemic Stroke Investigators. Abciximab in ischemic stroke: a randomized, double blind, placebocontrolled, dose-escalation study. Stroke 2000;31:601-609
16. Abumiya T, Lucero J, Heo HJ, et al. Activated microvessels expressed vascular endothelial growth factor and integrin alphaVbetaIII during focal cerebral ischemia. J Cerebral Blood Flow and Metabolism 1999;19:1038-1050
17. DeGraba TJ, Siren AL, Penix L, et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke 1998;29:1405-1410
18. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126
19. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999;20:1555-1564
20. The EPIC Investigators. The use of a monoclonal antibody directed against the platelet glyocoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961
21. Kereiakes DJ. Oral blockade of the platelet glycoprotien IIb/IIIa receptor: fact or fancy? American Heart Journal 138: S39-S46
22. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularizations. N Engl J Med 1997;336:1689-1696
23. The Epistent Investigators. Randomized placebo-controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with the use of platelet glycoprotein IIb/IIIa blockade. Lancet 352:87-92
24. Topol EJ, Califf RM, Weisman HF, et al. Randomized trial of coronary interventions with an antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis. Lancet 1994;343:881-886
25. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 1999;1945-1950
26. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52
27. Peipgras DG, Morgan MK, Sundt TM, et al. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 1988;68:532-536
28. Sundt TM, Sandok BA, Whisnant JP. Carotid endarterectomy: complications and preoperative assessment of risk. Mayo Clinic Proceedings 1975;50:301-306
29. Mori T, Fukuoka M, Kazita K, Mima T, Mori K. Intraventricular hemorrhage after carotid stenting. J Endovascular Surgery 1999;6;337-341
30. Qureshi AI, Saadf M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002;33;1916-1919
31. Willfort-Ehringer A, Ahmadi R, Gschwandtner M, Haumer M, Lang W, Minar E. Single-center experience with carotid stent restenosis. J Endovascular Ther 2002;9:299-307
32. Hofmann R, Kerschner K, Steinwender C, Kypta A, Dietmar B, Leisch F. Abciximab bolus injection does not reduce cerebral ischemic complication of elective carotid artery stenting: a randomized study. Stroke 2002;33:725-727
33. Schneiderman J, Morag B, Gerniak A, et al. Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results. J Endovasc Ther 2000;7:263-272